Work

Abstract 1646: Elucidating the molecular mechanism of action of the first in human SMARCA2 selective degrader PRT3789

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1646

Authors: Min Wang, Miles Cowart, Joy Cote, Justin Kurian, Stephanie Rodgers, Chaoyi Xu, Corey Basch, Philip Pitis, Klare Bersch, Raul Leal, Liang Lu, Michael Hulse, Andrew Moore, Alexander Grego, Joseph Rager, Tom Emm, Koichi Ito, Neha Bhagwat, Andrew Combs, Sandy Geeganage, Peggy Scherle

Institution: Prelude Therapeutics Incorporated (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625770

Cites:

Cited by: 2

Related to: 10